According to the report, global demand for active pharmaceutical ingredient market was valued at USD 148.22 billion in 2015, is expected to reach USD 213.84 billion in 2021 and is anticipated to grow at a CAGR of 6.3% between 2016 and 2021. APIs are frequently referred as “bulk pharmaceuticals”. The active pharmaceutical ingredient is a biologically active portion of any pharmaceutical drug. Occasionally, API needs cofactor in order to attain specific effects on the body.

[wptab name=’Report Description’ active=”1” ]
According to the report, global demand for active pharmaceutical ingredient market was valued at USD 148.22 billion in 2015, is expected to reach USD 213.84 billion in 2021 and is anticipated to grow at a CAGR of 6.3% between 2016 and 2021.

Active pharmaceutical ingredient (API) is used in the manufacturing of a pharmaceutical drug as a biologically active compound. API is an organic compound which has unique chemical structure and stereochemistry. Any medication is made up of two portions. The first is the active pharmaceutical ingredients, which is the essential element of the drug. The second is known as an excipient which is an inner part of the drug. The active pharmaceutical ingredient is the chemically active substance, which is intended to deliver the desirable impact in the body.

The market for API is driven by a number of factors, such as increasing prevalence of chronic diseases, technological advancements in the API manufacturing, and growing incidences of age-related diseases. Furthermore, patent expiration of major drugs that increased generic drug sales, government initiatives flourishing the market growth. However, stringent regulatory requirement and decline in global economics may curb the worldwide active pharmaceutical ingredient market.

The global active pharmaceutical ingredient market is broadly segmented based on API synthesis, type of manufacturing, type of API, and type of drug, application and by region. On the basis of API, synthesis market is segmented into biotech API, synthetic chemical API, and HPAPI (Highly Potent Active Pharmaceutical Ingredient). The biotech API is the leading segment and acquired a significant share in overall API market in 2015. On the basis of the type of manufacturing, the market is segmented into API contract manufacturing and in-house API manufacturing. The contract manufacturing emerged as major segment due to lower cost and higher quality of production of the API. Type segment of API includes synthetic API and biological API.

By type of drug, the market is segmented into branded drugs, generic drugs, and OTC (Over the Counter) drugs.  The generic prescription drugs segment is expected to witness the highest growth in the upcoming years due to their low cost compared to branded drugs. Cardiology, oncology, anti-inflammatory, gastrointestinal and others are the key therapeutic application segmentation of API market. According to World Health Organization (WHO), cancer was one of the major causes of mortality across the globe. Thus, the oncology segment is expected to be the fastest-growing segment of the global API market.

North America dominated the global API market in 2015 followed by Europe due to development in the pharmaceutical industry, and technological advancement in API. Asia-Pacific is considered as a fastest growing market for active pharmaceutical ingredient due to increasing new drug application in this region.

Major players in active pharmaceutical ingredient market are Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others.
[/wptab]
[wptab name=’Table of content’]

• Chapter 1. Preface
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
• Chapter 2. Executive Summary
  • 2.1. Global Active pharmaceutical ingredient Market, 2015 – 2021, (USD Billion)
  • 2.2. Active pharmaceutical ingredient: Market snapshot
• Chapter 3. Active pharmaceutical ingredient Market: Industry Analysis
  • 3.1. Active pharmaceutical ingredient: Market dynamics
  • 3.2. Market Drivers
    • 3.2.1. Increasing prevalence of chronic diseases
    • 3.2.2. Technological advancements in the API
    • 3.2.3. Patent expiration of major drugs that increased generic drug sales
    • 3.2.4. Government initiatives
  • 3.3. Restraints
    • 3.3.1. Stringent regulatory requirement
    • 3.3.2. Decline in global economics
  • 3.4. Opportunity
    • 3.4.1. Demand for active pharmaceutical ingredient for various diseases treatment
  • 3.5. Porter’s Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis by API synthesis segment
    • 3.6.2. Market attractiveness analysis by type of manufacturing segment
    • 3.6.3. Market attractiveness analysis by type of API segment
    • 3.6.4. Market attractiveness analysis by drug type segment
    • 3.6.5. Market attractiveness analysis by Application segment
    • 3.6.6. Market attractiveness analysis by region segment
• Chapter 4. Global Active pharmaceutical ingredient Market: Competitive Landscape
  • 4.1. Company Market Share Analysis
    • 4.1.1. Global active pharmaceutical ingredient market: company market share, 2015
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Product Launch
    • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
    • 4.2.4. Research and Development, Product and Regional Expansion
  • 4.3. Price Trend Analysis
  • 4.4. Product Portfolio
  • 4.5. Patent Analysis (2011-2016)
    • 4.5.1. Patent Trend
    • 4.5.2. Patent Share by company
    • 4.5.3. By Region
• Chapter 5. Global Active pharmaceutical ingredient Market: API Synthesis Type Overview
  • 5.1. Global active pharmaceutical ingredient market share, by API Synthesis type, 2015 and 2021
  • 5.2. Global active pharmaceutical ingredient market for biotech APItype, 2015 – 2021(USD Billion)
  • 5.3. Global active pharmaceutical ingredient market for synthetic chemical API, 2015 – 2021 (USD Billion)
  • 5.4. Global active pharmaceutical ingredient market for HPAPI type, 2015 – 2021 (USD Billion)
• Chapter 6. Global active pharmaceutical ingredient Market: Type of Manufacturing Overview
  • 6.1. Global active pharmaceutical ingredient market share, by type of Manufacturing, 2015 and 2021
  • 6.2. Global active pharmaceutical ingredient market for contract manufacturing, 2015 – 2021(USD Billion)
  • 6.3. Global active pharmaceutical ingredient market for in-house API manufacturing, 2015 – 2021 (USD Billion)
• Chapter 7. Global active pharmaceutical ingredient Market: Type of API Overview
  • 7.1. Global active pharmaceutical ingredient market share for type of API , 2015 and 2021
  • 7.2. Global active pharmaceutical ingredient market for synthetic API, 2015 – 2021(USD Billion)
  • 7.3. Global active pharmaceutical ingredient market for biological API, 2015 – 2021 (USD Billion)
• Chapter 8. Global active pharmaceutical ingredient Market: Drug Type Overview
  • 8.1. Global active pharmaceutical ingredient market share for type of drug, 2015 and 2021
  • 8.2. Global active pharmaceutical ingredient market for branded drugs, 2015 – 2021(USD Billion)
  • 8.3. Global active pharmaceutical ingredient market for generic drugs, 2015 – 2021 (USD Billion)
  • 8.4. Global active pharmaceutical ingredient market for OTC drugs, 2015 – 2021 (USD Billion)
• Chapter 9. Global active pharmaceutical ingredient Market: Application Overview
  • 9.1. Global active pharmaceutical ingredient market share for application , 2015 and 2021
  • 9.2. Global active pharmaceutical ingredient market for cardiology, 2015 – 2021(USD Billion)
  • 9.3. Global active pharmaceutical ingredient market for oncology, 2015 – 2021 (USD Billion)
  • 9.4. Global active pharmaceutical ingredient market for anti-inflammatory, 2015 – 2021 (USD Billion)
  • 9.5. Global active pharmaceutical ingredient market for gastrointestinal, 2015 – 2021 (USD Billion)
  • 9.6. Global active pharmaceutical ingredient market for others, 2015 – 2021 (USD Billion)
• Chapter 10. Global active pharmaceutical ingredient Market: Regional Analysis
  • 10.1. Global active pharmaceutical ingredient market: Regional overview
    • 10.1.1. Global active pharmaceutical ingredient market share, by region, 2015 and 2021
  • 10.2. North America
    • 10.2.1. North America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
    • 10.2.2. North America active pharmaceutical ingredient market revenue, type of Manufacturing, 2015 – 2021 (USD Billion)
    • 10.2.3. North America active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
    • 10.2.4. North America active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
    • 10.2.5. North America active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
    • 10.2.6. U.S.
      • 10.2.6.1. U.S active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.2.6.2. U.S active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.2.6.3. U.S active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.2.6.4. U.S active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
      • 10.2.6.5. U.S active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
  • 10.3. Europe
    • 10.3.1. Europe active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
    • 10.3.2. Europe active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
    • 10.3.3. Europe active pharmaceutical ingredient market revenue, by type of API , 2015 – 2021 (USD Billion)
    • 10.3.4. Europe active pharmaceutical ingredient market revenue, by drug type , 2015 – 2021 (USD Billion)
    • 10.3.5. Europe active pharmaceutical ingredient market revenue, by application , 2015 – 2021 (USD Billion)
    • 10.3.6. UK
      • 10.3.6.1. UK active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.3.6.2. UK active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.3.6.3. UK active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.3.6.4. UK active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
      • 10.3.6.5. UK active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
    • 10.3.7. France
      • 10.3.7.1. France active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.3.7.2. France active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.3.7.3. France active pharmaceutical ingredient market revenue, by type of API 2015 – 2021 (USD Billion)
      • 10.3.7.4. France active pharmaceutical ingredient market revenue, by drug type 2015 – 2021 (USD Billion)
      • 10.3.7.5. France active pharmaceutical ingredient market revenue, by application 2015 – 2021 (USD Billion)
    • 10.3.8. Germany
      • 10.3.8.1. Germany active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.3.8.2. Germany active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.3.8.3. Germany active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.3.8.4. Germany active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion
      • 10.3.8.5. Germany active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
  • 10.4. Asia Pacific
    • 10.4.1. Asia Pacific active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
    • 10.4.2. Asia Pacific active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
    • 10.4.3. Asia Pacific active pharmaceutical ingredient market revenue, by type of API , 2015 – 5 – 2021 (USD Billion)
    • 10.4.4. Asia Pacific active pharmaceutical ingredient market revenue, by drug type , 2015 – 5 – 2021 (USD Billion)
    • 10.4.5. Asia Pacific active pharmaceutical ingredient market revenue, by application , 2015 – 5 – 2021 (USD Billion)
    • 10.4.6. China
      • 10.4.6.1. China active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.4.6.2. China active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.4.6.3. China active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.4.6.4. China active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
      • 10.4.6.5. China active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
    • 10.4.7. India
      • 10.4.7.1. India active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.4.7.2. India active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.4.7.3. India active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.4.7.4. India active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
      • 10.4.7.5. India active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
  • 10.5. Latin America
    • 10.5.1. Latin America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
    • 10.5.2. Latin America active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
    • 10.5.3. Latin America active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
    • 10.5.4. Latin America active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
    • 10.5.5. Latin America active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
    • 10.5.6. Brazil
      • 10.5.6.1. Brazil active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.5.6.2. Brazil active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.5.6.3. Brazil active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.5.6.4. Brazil active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
      • 10.5.6.5. Brazil active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
  • 10.6. Middle East & Africa
    • 10.6.1. Middle East & Africa active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
    • 10.6.2. Middle East & Africa active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
    • 10.6.3. Middle East & Africa active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
    • 10.6.4. Middle East & Africa active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
    • 10.6.5. Middle East & Africa active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
• Chapter 11. Company Profiles
  • 11.1. Novartis International AG
    • 11.1.1. Overview
    • 11.1.2. Financials
    • 11.1.3. Product portfolio
    • 11.1.4. Business strategy
    • 11.1.5. Recent developments
  • 11.2. Pfizer
    • 11.2.1. Overview
    • 11.2.2. Financials
    • 11.2.3. Product portfolio
    • 11.2.4. Business strategy
    • 11.2.5. Recent developments
  • 11.3. Aurobindo
    • 11.3.1. Overview
    • 11.3.2. Financials
    • 11.3.3. Product portfolio
    • 11.3.4. Business strategy
    • 11.3.5. Recent developments
  • 11.4. Albemarle Corporation
    • 11.4.1. Overview
    • 11.4.2. Financials
    • 11.4.3. Product portfolio
    • 11.4.4. Business strategy
    • 11.4.5. Recent developments
  • 11.5. Boehringer Ingelheim
    • 11.5.1. Overview
    • 11.5.2. Financials
    • 11.5.3. Product portfolio
    • 11.5.4. Business strategy
    • 11.5.5. Recent developments
  • 11.6. BASF SE
    • 11.6.1. Overview
    • 11.6.2. Financials
    • 11.6.3. Product portfolio
    • 11.6.4. Business strategy
    • 11.6.5. Recent developments
• Chapter 12. Patents
  • 12.1. U.S. (US Patents)
  • 12.2. Europe (EP documents)
  • 12.3. Japan (Abstracts of Japan)
  • 12.4. Global (WIPO (PCT))

List of Figures 
1. Global active pharmaceutical ingredient market segmentation API synthesis, type of manufacturing, type of API, type of drug, application, and geography
2. Global active pharmaceutical ingredient  market, 2015 – 2021 (USD Billion)
3. Porter’s five forces analysis: active pharmaceutical ingredient market
4. Market attractiveness analysis by API synthesis segment
5. Market attractiveness analysis by type of manufacturing segment
6. Market attractiveness analysis by type of API segment
7. Market attractiveness analysis by drug type segment
8. Market attractiveness analysis by application segment
9. Market attractiveness analysis by regional segment
10. Global active pharmaceutical ingredient market : Company Market Share, 2015
11. Price Trend Analysis : Active pharmaceutical ingredient market
12. Patent trend between 2011 -2016
13. Patent Share by Company between 2011 – 2016
14. Patent Share by Region between 2011 – 2016
15. Global active pharmaceutical ingredient market share, by API synthesis, 2015 -2021
16. Global active pharmaceutical ingredient market for biotech API, 2015 – 2021 (USD Billion)
17. Global active pharmaceutical ingredient market for synthetic chemical API, 2015 – 2021 (USD Billion)
18. Global active pharmaceutical ingredient market for HPAPI, 2015 – 2021 (USD Billion)
19. Global active pharmaceutical ingredient market share, by type of manufacturing, 2015 -2021
20. Global active pharmaceutical ingredient market for contract manufacturing management (IAM), 2015 – 2021 (USD Billion)
21. Global active pharmaceutical ingredient market for in-house API manufacturing, 2015 – 2021 (USD Billion)
22. Global active pharmaceutical ingredient market share, by type of API, 2015 -2021
23. Global active pharmaceutical ingredient market for synthetic API, 2015 – 2021 (USD Billion)
24. Global active pharmaceutical ingredient market for biological API, 2015 – 2021 (USD Billion)
25. Global active pharmaceutical ingredient market share, by drug type, 2015 -2021
26. Global active pharmaceutical ingredient market for branded drugs, 2015 – 2021 (USD Billion)
27. Global active pharmaceutical ingredient market for generic drugs, 2015 – 2021 (USD Billion)
28. Global active pharmaceutical ingredient market for OTC drugs, 2015 – 2021 (USD Billion)
29. Global active pharmaceutical ingredient market share, by application, 2015 -2021
30. Global active pharmaceutical ingredient market for cardiology, 2015 – 2021 (USD Billion)
31. Global active pharmaceutical ingredient market for oncology, 2015 – 2021 (USD Billion)
32. Global active pharmaceutical ingredient market for anti-inflammatory, 2015 – 2021 (USD Billion)
33. Global active pharmaceutical ingredient market for gastrointestinal, 2015 – 2021 (USD Billion)
34. Global active pharmaceutical ingredient market for others, 2015 – 2021 (USD Billion)
35. Global active pharmaceutical ingredient market share, by region, 2015 – 2021
36. North America active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
37. U.S. active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
38. Europe active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
39. UK active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
40. France active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
41. Germany active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
42. Asia Pacific active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
43. China active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
44. Japan active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
45. India active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
46. Latin America active pharmaceutical ingredient market, 2015-2021, (USD Billion)
47. Brazil active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
48. Middle East & Africa active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)

List of Tables

1. Global active pharmaceutical ingredient  market snapshot
2. Drivers for active pharmaceutical ingredient  market: Impact analysis
3. Restraints of active pharmaceutical ingredient  market: Impact analysis
4. North America active pharmaceutical ingredient  market revenue, by API synthesis, 2015 – 2021 (USD Billion)
5. North America active pharmaceutical ingredient  market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
6. North America active pharmaceutical ingredient  market revenue, by Type of API, 2015 – 2021 (USD Billion)
7. North America active pharmaceutical ingredient  market revenue, by drug type, 2015 – 2021 (USD Billion)
8. North America active pharmaceutical ingredient  market revenue, by application, 2015 – 2021 (USD Billion)
9. U.S. active pharmaceutical ingredient  market revenue, by API synthesis, 2015 – 2021 (USD Billion)
10. U.S. active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
11. U.S. active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
12. U.S. active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
13. U.S. active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
14. Europe active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
15. Europe active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
16. Europe active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
17. Europe active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
18. Europe active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
19. UK active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
20. UK active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
21. UK active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
22. UK active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
23. UK active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
24. France active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
25. France active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
26. France active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
27. France active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
28. France active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
29. Germany active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
30. Germany active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
31. Germany active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
32. Germany active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
33. Germany active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
34. Asia-Pacific active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
35. Asia-Pacific active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
36. Asia-Pacific active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
37. Asia-Pacific active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
38. Asia-Pacific active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
39. China active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
40. China active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
41. China active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
42. China active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
43. China active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
44. Japan active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
45. Japan active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
46. Japan active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
47. Japan active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
48. Japan active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
49. India active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
50. India active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
51. India active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
52. India active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
53. India active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
54. Latin America active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
55. Latin America active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
56. Latin America active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
57. Latin America active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
58. Latin America active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
59. Brazil active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
60. Brazil active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
61. Brazil active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
62. Brazil active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
63. Brazil active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
64. Middle East & Africa active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
65. Middle East & Africa active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
66. Middle East & Africa active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
67. Middle East & Africa active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
68. Middle East & Africa active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
[/wptab]
[wptab name=’Request For Sample’]

[contact-form-7 id=”7″ title=”Request For Sample”]

[/wptab]

[end_wptabset]